APA (7th ed.) Citation

ER, G., RT, E., E, G., KE, K., K, v. B., JN, B., . . . E, S. (2025). Aspyre Lung enables robust variant calling in samples that fail next generation sequencing quality control. Translational oncology, 62, 102565. https://doi.org/10.1016/j.tranon.2025.102565

Chicago Style (17th ed.) Citation

ER, Gray, et al. "Aspyre Lung Enables Robust Variant Calling in Samples That Fail Next Generation Sequencing Quality Control." Translational Oncology 62 (2025): 102565. https://doi.org/10.1016/j.tranon.2025.102565.

MLA (9th ed.) Citation

ER, Gray, et al. "Aspyre Lung Enables Robust Variant Calling in Samples That Fail Next Generation Sequencing Quality Control." Translational Oncology, vol. 62, 2025, p. 102565, https://doi.org/10.1016/j.tranon.2025.102565.